Importance and What to Watch Out for De Novo Donor Specific Anti-HLA Antibodies after Kidney Transplantation
- PMID: 30127708
- PMCID: PMC6097070
- DOI: 10.3346/jkms.2018.33.e228
Importance and What to Watch Out for De Novo Donor Specific Anti-HLA Antibodies after Kidney Transplantation
Conflict of interest statement
Disclosure: The author has no potential conflicts of interest to disclose.
Comment on
-
Characteristics and Clinical Significance of De Novo Donor-Specific Anti-HLA Antibodies after Kidney Transplantation.J Korean Med Sci. 2018 Jun 28;33(34):e217. doi: 10.3346/jkms.2018.33.e217. eCollection 2018 Aug 20. J Korean Med Sci. 2018. PMID: 30127706 Free PMC article.
References
-
- Sellarés J, de Freitas DG, Mengel M, Reeve J, Einecke G, Sis B, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant. 2012;12(2):388–399. - PubMed
-
- Süsal C, Ovens J, Mahmoud K, Döhler B, Scherer S, Ruhenstroth A, et al. No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: a collaborative transplant study report. Transplantation. 2011;91(8):883–887. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
